5-Bromo-6-methoxy-1H-benzo[d]imidazole, 95.0%, 25g

(4-(Trifluoromethoxy)benzyl)hydrazine dihydrochloride, 25g

5-(4,4''-Di-tert-butyl-[1,1':3',1''-terphenyl]-5'-yl)-N-((1S,2S)-2-(dimethylamino)cyclohexyl)picolinamide, 98%, 100mg

1,2,3-THIADIAZOL-4-YLMETHANOL, 95.0%, 2g

E-Plan phase EPLPHi S40x/0.65 infinity corrected IOS lens. Working distance 0.78 mm

Ethyl 7-amino-2-(methoxymethyl)-[1,2,4]triazolo[1,5-a]pyrimidine-6-carboxylate, 95%, 250mg

1-Benzylazetidine-2-carboxamide, 95.0%, 250mg

Ethyl 2-(oxetan-3-ylidene)acetate, 95.0%, 250mg

(2E)-1-(2-chlorophenyl)-3-(3,4-dimethoxyphenyl)prop-2-en-1-one, 95.0%, 2g

3-((Tert-butoxycarbonyl)amino)-3-(4-(methylthio)phenyl)propanoic acid, 97%, 5g

N1,N4-Di(buta-2,3-dien-1-yl)butane-1,4-diamine dihydrochloride, 95.0%, 25mg

Methyl (R)-(-)-3-Hydroxybutyrate>98.0%(GC)10mL

tert-Butyl (1-amino-4-methylpentan-2-yl)carbamate, 95.0%, 250mg